Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.

Ronco G, Brezzi S, Carozzi F, Dalla Palma P, Giorgi-Rossi P, Minucci D, Naldoni C, Segnan N, Zappa M, Zorzi M, Cuzick J; NTCC study group.

Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S230-2. Epub 2007 Sep 6.

PMID:
17822751
2.

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.

Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J; New Technologies for Cervical Cancer Working Group.

J Natl Cancer Inst. 2006 Jun 7;98(11):765-74.

PMID:
16757701
3.

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J.

J Natl Cancer Inst. 2009 Jan 21;101(2):88-99. doi: 10.1093/jnci/djn444. Epub 2009 Jan 13.

PMID:
19141778
4.

Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial.

Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, De Lillo M, Naldoni C, Pierotti P, Rizzolo R, Segnan N, Schincaglia P, Zorzi M, Confortini M, Cuzick J; New Technologies for Cervical Cancer screening Working Group.

Lancet Oncol. 2006 Jul;7(7):547-55.

PMID:
16814206
5.

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N; New Technologies for Cervical Cancer Screening Working Group.

J Natl Cancer Inst. 2008 Apr 2;100(7):492-501. doi: 10.1093/jnci/djn065. Epub 2008 Mar 25.

PMID:
18364502
6.

Screening for cervical cancer: new alternatives and research.

Lörincz AT.

Salud Publica Mex. 2003;45 Suppl 3:S376-87. Review.

PMID:
14746031
7.

HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology.

Ronco G, Cuzick J, Segnan N, Brezzi S, Carozzi F, Folicaldi S, Dalla Palma P, Del Mistro A, Gillio-Tos A, Giubilato P, Naldoni C, Polla E, Iossa A, Zorzi M, Confortini M, Giorgi-Rossi P; NTCC working group.

Eur J Cancer. 2007 Feb;43(3):476-80. Epub 2007 Jan 12.

PMID:
17223540
8.

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.

Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J; New Technologies for Cervical Cancer screening (NTCC) Working Group.

Lancet Oncol. 2010 Mar;11(3):249-57. doi: 10.1016/S1470-2045(09)70360-2. Epub 2010 Jan 18.

PMID:
20089449
9.

Human papillomavirus testing for primary screening of cervical cancer precursors.

Ratnam S, Franco EL, Ferenczy A.

Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):945-51.

10.

Value of high-risk HPV-DNA testing in the triage of ASCUS.

Silverloo I, Andrae B, Wilander E.

Acta Obstet Gynecol Scand. 2009;88(9):1006-10. doi: 10.1080/00016340903160952.

PMID:
19690991
11.

Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial.

Bergeron C, Giorgi-Rossi P, Cas F, Schiboni ML, Ghiringhello B, Dalla Palma P, Minucci D, Rosso S, Zorzi M, Naldoni C, Segnan N, Confortini M, Ronco G.

J Natl Cancer Inst. 2015 Jan 7;107(2). pii: dju423. doi: 10.1093/jnci/dju423. Print 2015 Feb.

12.

Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study.

Derchain SF, Sarian LO, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo RC, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K.

J Med Screen. 2008;15(2):97-104. doi: 10.1258/jms.2008.007061.

PMID:
18573778
13.
14.

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.

Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/78-89. Review.

PMID:
16950021
15.

Chapter 13: Primary screening of cervical cancer with human papillomavirus tests.

Franco EL.

J Natl Cancer Inst Monogr. 2003;(31):89-96. Review.

PMID:
12807951
16.

Cervical cancer screening in the 21st century: is it time to retire the PAP smear?

Wright TC Jr.

Clin Obstet Gynecol. 2007 Jun;50(2):313-23. Review.

PMID:
17513921
17.

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance, after six months delay: a three-year experience in an Iranian university hospital.

Yarandi F, Shojaei H, Eftekhar Z, Izadi-Mood N.

Aust N Z J Obstet Gynaecol. 2009 Apr;49(2):207-10. doi: 10.1111/j.1479-828X.2009.00960.x.

PMID:
19432613
18.

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies.

Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, Prendiville W, Paraskevaidis E.

Gynecol Oncol. 2007 Jan;104(1):232-46. Epub 2006 Nov 3. Review.

PMID:
17084886
19.

Human papillomavirus testing for primary cervical cancer screening.

Grce M, Davies P.

Expert Rev Mol Diagn. 2008 Sep;8(5):599-605. doi: 10.1586/14737159.8.5.599. Review.

PMID:
18785808
20.

Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial.

Ronco G, Cuzick J, Pierotti P, Cariaggi MP, Dalla Palma P, Naldoni C, Ghiringhello B, Giorgi-Rossi P, Minucci D, Parisio F, Pojer A, Schiboni ML, Sintoni C, Zorzi M, Segnan N, Confortini M.

BMJ. 2007 Jul 7;335(7609):28. Epub 2007 May 21.

Supplemental Content

Support Center